The National Institute for health and clinical excellence (NICE) has recommended the use of the drug golimumab (Simponi), in combination with methotrexate. This treatment will be available to adults whose rheumatoid arthritis (RA) has not responded adequately to conventional drugs of balneotherapy.
Neil Betteridge, Chief Executive of the Arthritis Care said: ' the rheumatoid arthritis (RA) is a terrible disease that affects people of all ages that doctors usually compare with cancer of the joints.
"Unless they are effectively manage invariably leads to the great pain and can process immobile people and they may not work." Therefore, having another available treatment option is great.'
Medicines anti-TNF can help to improve the quality of life for individuals living with RA. Nice recommendation promotes patient choice to provide more treatment options for people living with severe ar
If you have rheumatoid arthritis and I think that this treatment could be of help, talk with your clinical specialists to find out if you are eligible.
No comments:
Post a Comment